Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Tests Improved for Detection of Helicobacter Pylori Antigen

By LabMedica International staff writers
Posted on 28 Oct 2009
Tests for the of Helicobacter pylori antigen in stool samples have been improved. More...
These tests can be used for the diagnosis and management of active H. pylori infection.

Employing a combination of amplification technology and monoclonal antibodies, two noninvasive tests can be performed using a patient stool sample. They detect H. pylori antigen with a high degree of accuracy and can be used to diagnose current infection in both adult and pediatric patients. Unlike serology methods, these stool antigen tests can be used to detect active infection and to confirm the eradication of H. pylori following antibiotic therapy.

A rapid immunochromatographic membrane-based assay provides reliable results in just 15 minutes, without the need for special equipment. Called Rapid Hp StAR, the method is suitable for small volume testing in the laboratory or for near patient testing in gastroenterology clinics and doctors offices. This makes it convenient for monitoring the efficacy of antimicrobial treatment without the need for return hospital visits.

The second test, IDEIA Hp StAR, is a sensitive and specific enzyme immunoassay. The test is easy to perform using standard equipment, allowing the "test and treat” policy recommended by the European Helicobacter Study Group (EHSG) to be implemented in routine laboratories. It is suitable for both manual and automated testing and has demonstrated good performance when compared to the urea breath test and alternative enzyme immunoassays.

The two tests are produced by Oxoid (Basingstoke, UK), a microbiology company whose products are used in laboratories to help diagnose infectious diseases. Laura Ward, marketing manager, Oxoid commented, "The Hp StAR tests provide cost effective, noninvasive alternatives to the more invasive methods offered by many hospitals. They involve minimal discomfort for the patient, making them particularly suitable for pediatric use. Furthermore, the ability to detect active infections also helps to avoid the unnecessary administration of antibiotics."

Oxoid is part of Thermo Fisher Scientific Inc. (Waltham MA, USA). Thermo Scientific offers analytical instruments as well as laboratory equipment, software, services, consumables, and reagents to enable integrated laboratory workflow solutions. Fisher Scientific has a portfolio of laboratory equipment, chemicals, supplies, and services used in healthcare, scientific research, safety, and education.

Related Links:

Oxoid
Thermo Fisher Scientific Inc.




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Urine Analyzer
respons® UDS100
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.